Psychological outcomes in advanced cancer patients after receiving genomic tumor profiling results.
Vatter, S
Schlub, TE
Napier, CE
Best, MC
Bartley, N
Juraskova, I
Meiser, B
Ballinger, ML
Biesecker, BB
Goldstein, D
Thomas, DM
Butow, P
Members of the PiGeOn Project,
- Publisher:
- American Psychological Association
- Publication Type:
- Journal Article
- Citation:
- Health Psychology, 2022, 41, (6), pp. 396-408
- Issue Date:
- 2022-06
Closed Access
Filename | Description | Size | |||
---|---|---|---|---|---|
VatterHealthPsychology2022.pdf | 991.93 kB | Adobe PDF |
Copyright Clearance Process
- Recently Added
- In Progress
- Closed Access
This item is closed access and not available.
Full metadata record
Field | Value | Language |
---|---|---|
dc.contributor.author | Vatter, S | |
dc.contributor.author | Schlub, TE | |
dc.contributor.author | Napier, CE | |
dc.contributor.author | Best, MC | |
dc.contributor.author |
Bartley, N |
|
dc.contributor.author | Juraskova, I | |
dc.contributor.author | Meiser, B | |
dc.contributor.author | Ballinger, ML | |
dc.contributor.author | Biesecker, BB | |
dc.contributor.author | Goldstein, D | |
dc.contributor.author | Thomas, DM | |
dc.contributor.author | Butow, P | |
dc.contributor.author | Members of the PiGeOn Project, | |
dc.date.accessioned | 2022-11-24T04:27:05Z | |
dc.date.available | 2022-11-24T04:27:05Z | |
dc.date.issued | 2022-06 | |
dc.identifier.citation | Health Psychology, 2022, 41, (6), pp. 396-408 | |
dc.identifier.issn | 0278-6133 | |
dc.identifier.issn | 1930-7810 | |
dc.identifier.uri | http://hdl.handle.net/10453/163722 | |
dc.description.abstract | BACKGROUND: Comprehensive tumor genomic profiling (CGP) offers hope for personalized treatment for cancer patients when other treatment options have been exhausted. However, receipt of nonactionable or ambiguous results could be an ongoing source of distress. We investigated patterns of hope, anxiety, depression, and CGP-specific anxiety in advanced cancer patients after receiving CGP results and 2-3 months later. METHOD: Participants were enrolled in a longitudinal psychosocial substudy, embedded in the Molecular Screening and Therapeutics Program, and had advanced solid cancers of any histological type with sufficient and accessible tissue for CGP. At T0 (before receiving CGP results), 1,431 participants completed sociodemographic, disease and psychosocial measures. At T1 (1-4 weeks after receiving CGP results) and T2 (2-3 months post-T1), 374 participants completed psychological outcome measures. Predictors of outcomes at T2 were identified using multinomial logistic regression. RESULTS: Approximately 75% of participants did not experience significant hopelessness or distress at T1 and T2. Hope decreased by T2, yet general anxiety and CGP-specific anxiety also decreased. Receiving actionable results did not impact psychological outcomes at T2. At T2, lower hope, and higher anxiety, depression and CGP-specific anxiety were associated with lower self-efficacy. Psychological and demographic factors (age, socioeconomic status, language, medical occupation, urban living, family history of cancer) independently predicted one or more psychological trajectories. Worse health status and perceived susceptibility to cancer progression predicted hope and anxiety trajectories. CONCLUSION: Further research on interventions to best support patients undergoing CGP with high anxiety, hopelessness, fear of cancer progression, and poorer health is urgently needed. (PsycInfo Database Record (c) 2022 APA, all rights reserved). | |
dc.format | ||
dc.language | eng | |
dc.publisher | American Psychological Association | |
dc.relation.ispartof | Health Psychology | |
dc.relation.isbasedon | 10.1037/hea0001181 | |
dc.rights | info:eu-repo/semantics/closedAccess | |
dc.subject | 11 Medical and Health Sciences, 13 Education, 17 Psychology and Cognitive Sciences | |
dc.subject.classification | Public Health | |
dc.subject.mesh | Anxiety | |
dc.subject.mesh | Anxiety Disorders | |
dc.subject.mesh | Depression | |
dc.subject.mesh | Genomics | |
dc.subject.mesh | Health Status | |
dc.subject.mesh | Humans | |
dc.subject.mesh | Neoplasms | |
dc.subject.mesh | Anxiety | |
dc.subject.mesh | Anxiety Disorders | |
dc.subject.mesh | Depression | |
dc.subject.mesh | Genomics | |
dc.subject.mesh | Health Status | |
dc.subject.mesh | Humans | |
dc.subject.mesh | Neoplasms | |
dc.subject.mesh | Humans | |
dc.subject.mesh | Neoplasms | |
dc.subject.mesh | Depression | |
dc.subject.mesh | Anxiety | |
dc.subject.mesh | Anxiety Disorders | |
dc.subject.mesh | Genomics | |
dc.subject.mesh | Health Status | |
dc.title | Psychological outcomes in advanced cancer patients after receiving genomic tumor profiling results. | |
dc.type | Journal Article | |
utslib.citation.volume | 41 | |
utslib.location.activity | United States | |
utslib.for | 11 Medical and Health Sciences | |
utslib.for | 13 Education | |
utslib.for | 17 Psychology and Cognitive Sciences | |
pubs.organisational-group | /University of Technology Sydney | |
pubs.organisational-group | /University of Technology Sydney/Faculty of Health | |
utslib.copyright.status | closed_access | * |
pubs.consider-herdc | false | |
dc.date.updated | 2022-11-24T04:27:04Z | |
pubs.issue | 6 | |
pubs.publication-status | Published | |
pubs.volume | 41 | |
utslib.citation.issue | 6 |
Abstract:
BACKGROUND: Comprehensive tumor genomic profiling (CGP) offers hope for personalized treatment for cancer patients when other treatment options have been exhausted. However, receipt of nonactionable or ambiguous results could be an ongoing source of distress. We investigated patterns of hope, anxiety, depression, and CGP-specific anxiety in advanced cancer patients after receiving CGP results and 2-3 months later. METHOD: Participants were enrolled in a longitudinal psychosocial substudy, embedded in the Molecular Screening and Therapeutics Program, and had advanced solid cancers of any histological type with sufficient and accessible tissue for CGP. At T0 (before receiving CGP results), 1,431 participants completed sociodemographic, disease and psychosocial measures. At T1 (1-4 weeks after receiving CGP results) and T2 (2-3 months post-T1), 374 participants completed psychological outcome measures. Predictors of outcomes at T2 were identified using multinomial logistic regression. RESULTS: Approximately 75% of participants did not experience significant hopelessness or distress at T1 and T2. Hope decreased by T2, yet general anxiety and CGP-specific anxiety also decreased. Receiving actionable results did not impact psychological outcomes at T2. At T2, lower hope, and higher anxiety, depression and CGP-specific anxiety were associated with lower self-efficacy. Psychological and demographic factors (age, socioeconomic status, language, medical occupation, urban living, family history of cancer) independently predicted one or more psychological trajectories. Worse health status and perceived susceptibility to cancer progression predicted hope and anxiety trajectories. CONCLUSION: Further research on interventions to best support patients undergoing CGP with high anxiety, hopelessness, fear of cancer progression, and poorer health is urgently needed. (PsycInfo Database Record (c) 2022 APA, all rights reserved).
Please use this identifier to cite or link to this item:
Download statistics for the last 12 months
Not enough data to produce graph